SDZXF (Sandoz Group AG) Total Liabilities: $12,647 Mil (As of Dec. 2025)


SDZXF Sandoz Group AG SDZXF
18 GF Score
Price $89.55
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Total Liabilities?

Sandoz Group AG SDZXF 18 Total Liabilities is $12,647 Mil as of Dec. 2025. GuruFocus rates SDZXF with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Sandoz Group AG's Total Liabilities for the quarter that ended in Dec. 2025 was $12,647 Mil.

Sandoz Group AG's quarterly Total Liabilities increased from Dec. 2024 ($11,743.00 Mil) to Jun. 2025 ($12,790.00 Mil) but then declined from Jun. 2025 ($12,790.00 Mil) to Dec. 2025 ($12,647.00 Mil).

Sandoz Group AG's annual Total Liabilities increased from Dec. 2023 ($10,776.00 Mil) to Dec. 2024 ($11,743.00 Mil) and increased from Dec. 2024 ($11,743.00 Mil) to Dec. 2025 ($12,647.00 Mil).

Sandoz Group AG Total Liabilities Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Total Liabilities Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Liabilities
8,797.00 10,776.00 11,743.00 12,647.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial 10,776.00 10,951.00 11,743.00 12,790.00 12,647.00
SDZXF
18GF Score
Sandoz Group AG SDZXF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sandoz Group AG's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6895+(5010+442
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+300+0)
=12,647

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=22032-9385
=12,647

Sandoz Group AG's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6895+(5010+442
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+300+0)
=12,647

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=22032-9385
=12,647

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $12,647 Mil mean?
Sandoz Group AG (SDZXF) has a Total Liabilities of $12,647 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sandoz Group AG and its competitors.
Is Sandoz Group AG's Total Liabilities too high?
Sandoz Group AG's current Total Liabilities is $12,647 Mil. Overall, Sandoz Group AG has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Total Liabilities compare to ZTS and UTHR?
Sandoz Group AG's Total Liabilities of $12,647 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sandoz Group AG and its competitors. Sandoz Group AG's current Total Liabilities is $12,647 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (SDZXF) has a current Total Liabilities of $12,647 Mil. The current Total Liabilities is $12,647 Mil. Sandoz Group AG's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Sandoz Group AG (SDZXF), the current Total Liabilities is $12,647 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
18GF Score

Get the complete analysis for SDZXF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$89.55
Price